These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 20631072)
1. Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells. Mitchell K; Svenson KB; Longmate WM; Gkirtzimanaki K; Sadej R; Wang X; Zhao J; Eliopoulos AG; Berditchevski F; Dipersio CM Cancer Res; 2010 Aug; 70(15):6359-67. PubMed ID: 20631072 [TBL] [Abstract][Full Text] [Related]
2. Comparative use of CRISPR and RNAi to modulate integrin α3β1 in triple negative breast cancer cells reveals that some pro-invasive/pro-metastatic α3β1 functions are independent of global regulation of the transcriptome. Kenney J; Ndoye A; Lamar JM; DiPersio CM PLoS One; 2021; 16(7):e0254714. PubMed ID: 34270616 [TBL] [Abstract][Full Text] [Related]
3. Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer. Aggarwal A; Al-Rohil RN; Batra A; Feustel PJ; Jones DM; DiPersio CM BMC Cancer; 2014 Jun; 14():459. PubMed ID: 24950714 [TBL] [Abstract][Full Text] [Related]
4. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo. Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121 [TBL] [Abstract][Full Text] [Related]
5. Integrin α3β1 controls mRNA splicing that determines Cox-2 mRNA stability in breast cancer cells. Subbaram S; Lyons SP; Svenson KB; Hammond SL; McCabe LG; Chittur SV; DiPersio CM J Cell Sci; 2014 Mar; 127(Pt 6):1179-89. PubMed ID: 24434582 [TBL] [Abstract][Full Text] [Related]
6. Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma. Zhou B; Gibson-Corley KN; Herndon ME; Sun Y; Gustafson-Wagner E; Teoh-Fitzgerald M; Domann FE; Henry MD; Stipp CS Mol Cancer Res; 2014 Jan; 12(1):143-154. PubMed ID: 24002891 [TBL] [Abstract][Full Text] [Related]
7. Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor. Paquette B; Therriault H; Desmarais G; Wagner R; Royer R; Bujold R Br J Cancer; 2011 Aug; 105(4):534-41. PubMed ID: 21792195 [TBL] [Abstract][Full Text] [Related]
8. Targeting of COX-2 expression by recombinant adenovirus shRNA attenuates the malignant biological behavior of breast cancer cells. Tu B; Ma TT; Peng XQ; Wang Q; Yang H; Huang XL Asian Pac J Cancer Prev; 2014; 15(20):8829-36. PubMed ID: 25374215 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in glioma. Rao Malla R; Gopinath S; Alapati K; Gorantla B; Gondi CS; Rao JS Mol Carcinog; 2013 Oct; 52(10):777-90. PubMed ID: 22495828 [TBL] [Abstract][Full Text] [Related]
10. Alpha3beta1 integrin in epidermis promotes wound angiogenesis and keratinocyte-to-endothelial-cell crosstalk through the induction of MRP3. Mitchell K; Szekeres C; Milano V; Svenson KB; Nilsen-Hamilton M; Kreidberg JA; DiPersio CM J Cell Sci; 2009 Jun; 122(Pt 11):1778-87. PubMed ID: 19435806 [TBL] [Abstract][Full Text] [Related]
11. Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis. Boosani CS; Mannam AP; Cosgrove D; Silva R; Hodivala-Dilke KM; Keshamouni VG; Sudhakar A Blood; 2007 Aug; 110(4):1168-77. PubMed ID: 17426256 [TBL] [Abstract][Full Text] [Related]
12. NDRG2 controls COX-2/PGE₂-mediated breast cancer cell migration and invasion. Kim MJ; Kim HS; Lee SH; Yang Y; Lee MS; Lim JS Mol Cells; 2014 Oct; 37(10):759-65. PubMed ID: 25256221 [TBL] [Abstract][Full Text] [Related]
13. CD151 promotes α3β1 integrin-dependent organization of carcinoma cell junctions and restrains collective cell invasion. Zevian SC; Johnson JL; Winterwood NE; Walters KS; Herndon ME; Henry MD; Stipp CS Cancer Biol Ther; 2015; 16(11):1626-40. PubMed ID: 26418968 [TBL] [Abstract][Full Text] [Related]
14. COX-2 dependent regulation of mechanotransduction in human breast cancer cells. Yoon AR; Stasinopoulos I; Kim JH; Yong HM; Kilic O; Wirtz D; Bhujwalla ZM; An SS Cancer Biol Ther; 2015; 16(3):430-7. PubMed ID: 25701047 [TBL] [Abstract][Full Text] [Related]
15. Integrin α3β1 as a breast cancer target. Subbaram S; Dipersio CM Expert Opin Ther Targets; 2011 Oct; 15(10):1197-210. PubMed ID: 21838596 [TBL] [Abstract][Full Text] [Related]
16. Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization. Varzavand A; Drake JM; Svensson RU; Herndon ME; Zhou B; Henry MD; Stipp CS Clin Exp Metastasis; 2013 Apr; 30(4):541-52. PubMed ID: 23224938 [TBL] [Abstract][Full Text] [Related]
17. Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression. Nieves-Alicea R; Colburn NH; Simeone AM; Tari AM Breast Cancer Res Treat; 2009 Mar; 114(2):203-9. PubMed ID: 18386173 [TBL] [Abstract][Full Text] [Related]
18. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression. Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544 [TBL] [Abstract][Full Text] [Related]